Provided by Tiger Trade Technology Pte. Ltd.

Ventyx Biosciences, Inc.

7.94
-1.4400-15.35%
Post-market: 7.990.0500+0.63%18:07 EST
Volume:4.61M
Turnover:38.16M
Market Cap:566.59M
PE:-5.30
High:8.89
Open:8.88
Low:7.61
Close:9.38
52wk High:10.55
52wk Low:0.7830
Shares:71.36M
Float Shares:53.56M
Volume Ratio:4.35
T/O Rate:8.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4991
EPS(LYR):-1.9732
ROE:-45.35%
ROA:-28.47%
PB:2.96
PE(LYR):-4.02

Loading ...

Ventyx Biosciences Raised to Buy From Neutral by HC Wainwright & Co.

Dow Jones
·
Nov 05

Ventyx Biosciences upgraded to Buy from Neutral at H.C. Wainwright

TIPRANKS
·
Nov 05

Ventyx Biosciences Inc expected to post a loss of 45 cents a share - Earnings Preview

Reuters
·
Nov 01

Oppenheimer Raises Price Target on Ventyx Biosciences to $14 From $9, Keeps Outperform Rating

MT Newswires Live
·
Oct 27

Ventyx Biosciences Is Maintained at Outperform by Oppenheimer

Dow Jones
·
Oct 27

Ventyx Biosciences : Oppenheimer Raises Target Price to $14 From $9

THOMSON REUTERS
·
Oct 27

Promising Phase II Trial Results of VTX3232 Bolster Buy Rating for Ventyx Biosciences

TIPRANKS
·
Oct 24

Stock Track | Ventyx Biosciences Soars 5.15% on Positive Phase 2 Results for Obesity and Cardiovascular Risk Drug

Stock Track
·
Oct 24

Stock Track | Ventyx Biosciences Soars 5.15% on Positive Phase 2 Trial Results for Obesity and Cardiovascular Risk Drug

Stock Track
·
Oct 24

Stock Track | Ventyx Biosciences Plunges 8.33% Despite Positive Phase 2 Results for Heart Drug VTX3232

Stock Track
·
Oct 24

Sector Update: Health Care Stocks Mixed Late Afternoon

MT Newswires Live
·
Oct 24

Crude Oil Surges 5%; American Airlines Shares Jump After Q3 Results

Benzinga
·
Oct 24

Top Midday Gainers

MT Newswires Live
·
Oct 24

BUZZ-U.S. STOCKS ON THE MOVE-LendingClub, Hasbro, Intel

Reuters
·
Oct 24

BUZZ-U.S. STOCKS ON THE MOVE-Lam Research, Rivian Automotive, Eli Lilly

Reuters
·
Oct 24

Stock Track | Ventyx Biosciences Soars 90.82% on Positive Phase 2 Results for Obesity and Heart Disease Drug

Stock Track
·
Oct 23

Ventyx Biosciences Shares Nearly Double as Oral Heart Disease Drug Cuts Inflammation in Mid-Stage Trial; Last up 94.3%

THOMSON REUTERS
·
Oct 23

Analysts Offer Insights on Healthcare Companies: Ventyx Biosciences (VTYX) and Novavax (NVAX)

TIPRANKS
·
Oct 23

BUZZ-U.S. STOCKS ON THE MOVE-Blackstone, Darling Ingredients, Harmony Biosciences

Reuters
·
Oct 23

H.C. Wainwright Reaffirms Their Hold Rating on Ventyx Biosciences (VTYX)

TIPRANKS
·
Oct 23